FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matteo Zignol

Research Profile

Disorders

Procedures

Physiology

Concepts & Ideas

Geographic Areas

Peru

Co-author Network

Publications

TOP 3
William A Wells; Matteo Zignol; Alimuddin Zumla; Catharina C Boehme; Frank Gj Cobelens; Colleen Daniels; David Wesley Dowdy; Elizabeth Gardiner; Jan Gheuens; Peter Kim; Michael E Kimerling; Barry Kreiswirth; Christian Lienhardt; Khisi Mdluli; Madhukar Pai; Mark D Perkins; Trevor Peter; Marco Schito
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.
Sahal Al-Hajoj; Mais Al-Herbwai; Ruba Al-Omari; Fahad A Alrabiah; Abdulrahman A Alrajhi; Sahar I Al-Thawadi; Mario C Raviglione; Mohammed M Shoukri; Bright Varghese; Matteo Zignol; Alimuddin Zumla; Naila Abuljadayel; Ziad Memish
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
S Royce; C van Weezenbeek; M Dara; D Falzon; Philip C Hopewell; K Hyder; M D Richardson; Matteo Zignol
Multidrug resistance in new tuberculosis patients: burden and implications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matteo Zignol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: William A Wells; Matteo Zignol; Alimuddin Zumla; Catharina C Boehme; Frank Gj Cobelens; Colleen Daniels; David Wesley Dowdy; Elizabeth Gardiner; Jan Gheuens; Peter Kim; Michael E Kimerling; Barry Kreiswirth; Christian Lienhardt; Khisi Mdluli; Madhukar Pai; Mark D Perkins; Trevor Peter; Marco Schito
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.
The Lancet infectious diseases 2013;13(5):449-58.
2013: Sahal Al-Hajoj; Mais Al-Herbwai; Ruba Al-Omari; Fahad A Alrabiah; Abdulrahman A Alrajhi; Sahar I Al-Thawadi; Mario C Raviglione; Mohammed M Shoukri; Bright Varghese; Matteo Zignol; Alimuddin Zumla; Naila Abuljadayel; Ziad Memish
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
Antimicrobial agents and chemotherapy 2013;57(5):2161-6.
2013: S Royce; C van Weezenbeek; M Dara; D Falzon; Philip C Hopewell; K Hyder; M D Richardson; Matteo Zignol
Multidrug resistance in new tuberculosis patients: burden and implications.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013;17(4):511-3.
2013: Ireneaus Sindani; Bashir Suleiman; Ismail Adam; Peter Arube; Samiha Baghdadi; Amal Bassili; Dennis Falzon; Christopher Fitzpatrick; Matteo Zignol
Multidrug-resistant tuberculosis, Somalia, 2010-2011.
Emerging infectious diseases 2013;19(3):478-80.
2013: Alena Skrahina; Wayne van Gemert; Aksana Zalutskaya; Andrei Astrauko; Andrei Dadu; Masoud Dara; Pierpaolo de Colombani; Sven Hoffner; Henadz Hurevich; Valiantsin Rusovich; Evgeni Sahalchyk; Matteo Zignol
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.
Bulletin of the World Health Organization 2013;91(1):36-45.
2012: E V Kurbatova; Vaira Leimane; Carole D Mitnick; M I D Quelapio; Vija Riekstina; A Taylor; P Viiklepp; Matteo Zignol; M Danilovitz; D Falzon; V M Gammino; I Gelmanova; Salmaan Keshavjee; Jaime Bayona; M C Becerra; J Peter Cegielski
Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012;16(10):1335-43.
2012: Ekaterina V Kurbatova; Vaira Leimane; Carole D Mitnick; M I D Quelapio; Vija Riekstina; Allison Taylor; Piret Viiklepp; Matteo Zignol; Manfred Danilovitz; Dennis Falzon; Victoria M Gammino; Irina Gelmanova; Salmaan Keshavjee; Jaime Bayona; Mercedes Becerra; J Peter Cegielski
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects.
Tuberculosis (Edinburgh, Scotland) 2012;92(5):397-403.
2012: Alena Skrahina; Wayne van Gemert; Aksana Zalutskaya; Andrei Astrauko; Sven Hoffner; Henadz Hurevich; Valiantsin Rusovich; Evgeni Sahalchyk; Matteo Zignol
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.
The European respiratory journal 2012;39(6):1425-31.
2012: Bethany Lynn Hedt; Svitlana Lyepshina; Nguyen Viet Nhung; Wayne van Gemert; Frank van Leth; Matteo Zignol; Frank Cobelens; Saidi M Egwaga; Ted Cohen
Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling.
Epidemiology (Cambridge, Mass.) 2012;23(2):293-300.
2012: Matteo Zignol; Charalambos Sismanidis; Wayne van Gemert; Dennis Falzon; Katherine Floyd; Philippe Glaziou; Mario C Raviglione
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.
Bulletin of the World Health Organization 2012;90(2):111-119D.
2011: E V Kurbatova; Vaira Leimane; Carole D Mitnick; M I D Quelapio; Vija Riekstina; A Taylor; P Viiklepp; Matteo Zignol; M Danilovitz; D Falzon; V M Gammino; I Gelmanova; S Keshavjee; Jaime Bayona; M Becerra; J Peter Cegielski
Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2011;15(11):1553-5, i.
2011: V M Gammino; I Gelmanova; V Hollo; Ernesto Jaramillo; Salmaan Keshavjee; Vaira Leimane; Carole D Mitnick; M I D Quelapio; Michael L Rich; V Riektsina; A B Taylor; Thelma E Tupasi; Charles D Wells; Matteo Zignol; Jaime Bayona; M C Becerra; C Bonilla; P J Cegielski
Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2011;15(10):1315-22.
2011: P Samo Gudo; Matteo Zignol; S Ahmadova; E Borroni; M Brouwer; E Coelho; Z Cuna; S Maungate; Giovanni Battista Migliori; P Miotto; D M Cirillo
Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey.
The European respiratory journal 2011;38(1):222-4.
2011: L Rigouts; G Torrea; Frank van Leth; Matteo Zignol; D Basra; T M Chonde; P De Rijk; Saidi M Egwaga; A S Hoza; Armand Van Deun
Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2011;15(7):959-65.
2011: Matteo Zignol; Wayne van Gemert; Dennis Falzon; Ernesto Jaramillo; Léopold Blanc; Mario C Raviglione
Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(7):901-6.
2011: Helen E Jenkins; Matteo Zignol; Ted Cohen
Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009.
PloS one 2011;6(7):e22927.
2010: Neel Gandhi; Paul Nunn; Keertan Dheda; H Simon Schaaf; Matteo Zignol; Dick Van Soolingen; Paul Jensen; Jaime Bayona
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.
Lancet 2010;375(9728):1830-43.
2009: Tran N Buu; Mai N T Huyen; Nguyen N T Lan; Hoang Thi Quy; Nguyen V Hen; Matteo Zignol; Martien W Borgdorff; Dick Van Soolingen; Frank G J Cobelens
Mycobacterium tuberculosis genotype and case notification rates, rural Vietnam, 2003-2006.
Emerging infectious diseases 2009;15(10):1570-7.
2009: Abigail Wright; Matteo Zignol; Armand Van Deun; Dennis Falzon; Sabine Ruesch Gerdes; Knut Feldman; Sven Hoffner; Francis Drobniewski; Lucia Barrera; Dick Van Soolingen; Fadila Boulabhal; C N Paramasivan; Kai Man Kam; Satoshi Mitarai; Paul Nunn; Mario C Raviglione
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Lancet 2009;373(9678):1861-73.
2009: SE Ottmani; Matteo Zignol; N Bencheikh; L Laâsri; Léopold Blanc; Jaouad Mahjour
TB contact investigations: 12 years of experience in the National TB Programme, Morocco 1993-2004.
Eastern Mediterranean health journal = La revue de santé de la Méditerranée orientale = al-Majallah al-ṣiḥḥīyah li-sharq al-mutawassiṭ 2009;15(3):494-503.
2009: Pushpa Malla; Elisabeth Eva Kanitz; Mohammad Akhtar; Dennis Falzon; Knut Feldmann; Christian Gunneberg; Shyam Sundar Jha; Bhagwan Maharjan; Mohan Kumar Prasai; Bhabana Shrestha; Sharat Chandra Verma; Matteo Zignol
Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006.
PloS one 2009;4(12):e8313.
2008: Frank G J Cobelens; Einar Heldal; Michael E Kimerling; Carole D Mitnick; Laura J Podewils; Rajeswari Ramachandran; Hans L Rieder; Karin Weyer; Matteo Zignol
Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.
PLoS medicine 2008;5(7):e150.
2008: Ted Cohen; Caroline Colijn; Abigail Wright; Matteo Zignol; Alexander Pym; Megan Murray
Challenges in estimating the total burden of drug-resistant tuberculosis.
American journal of respiratory and critical care medicine 2008;177(12):1302-6.
2008: Andrea Boggio; Matteo Zignol; Ernesto Jaramillo; Paul Nunn; Geneviève Pinet; Mario Raviglione
Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB?
Health and human rights 2008;10(2):121-6.
2008: Timothy M Chonde; Basra Doulla; Frank van Leth; Sayoki G M Mfinanga; Nyagosya Range; Fred Lwilla; Saidi M Mfaume; Armand Van Deun; Matteo Zignol; Frank G J Cobelens; Saidi M Egwaga
Implementation of a national anti-tuberculosis drug resistance survey in Tanzania.
BMC public health 2008;8():427.
2008: Igor Raykhert; Kestutis Miskinis; Svitlana Lepshyna; Olga Kosinova; Anna Kovalyova; Risards Zaleskis; Paul Nunn; Matteo Zignol
HIV seroprevalence among new TB patients in the civilian and prisoner populations of Donetsk Oblast, Ukraine.
Scandinavian journal of infectious diseases 2008;40(8):655-62.
2008: Cesar A Bonilla; Aldo Crossa; Hector Oswaldo Jave; Carole D Mitnick; Ronal B Jamanca; Cesar Herrera; Luis Asencios; Alberto Mendoza; Jaime Bayona; Matteo Zignol; Ernesto Jaramillo
Management of extensively drug-resistant tuberculosis in Peru: cure is possible.
PloS one 2008;3(8):e2957.
2008: Ted Cohen; Caroline Colijn; Bryson Finklea; Abigail Wright; Matteo Zignol; Alexander Pym; Megan Murray
Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study.
PloS one 2008;3(6):e2363.
2007: Paul Nunn; Matteo Zignol; Ernesto Jaramillo; Abigail Wright; Haileyesus Getahun
Tb drug resistance: is it really a threat to Africa?
Ethiopian medical journal 2007;45(4):399-404.
2007: SE Ottmani; Matteo Zignol; Léopold Blanc; N Bencheikh; L Laâsri; Jaouad Mahjour
Improving the quality of cohort analysis by incorporating treatment outcomes of 'transferred in' TB cases.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2007;11(5):588-90.
2007: Matteo Zignol; Abigail Wright; Ernesto Jaramillo; Paul Nunn; Mario C Raviglione
Patients with previously treated tuberculosis no longer neglected.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):61-4.
2006: SE Ottmani; Matteo Zignol; N Bencheikh; L Laâsri; Noureddine Chaouki; Jaouad Mahjour
Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(12):1367-72.
2006: Matteo Zignol; Mehran S Hosseini; Abigail Wright; Catharina Lambregts-van Weezenbeek; Paul Nunn; Catherine J Watt; Brian Williams; Christopher Dye
Global incidence of multidrug-resistant tuberculosis.
The Journal of infectious diseases 2006;194(4):479-85.
2006: Katherine Floyd; Vijay K Arora; K J R Murthy; Knut Lonnroth; Neeta Singla; Y Akbar; Matteo Zignol; Mukund Uplekar
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India.
Bulletin of the World Health Organization 2006;84(6):437-45.
2006: Simone Cesaro; Matteo Zignol; Alberto Burlina; Gloria Tridello; Gianluca Visintin; Chiara Messina
Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation.
Pediatric transplantation 2006;10(2):255-8.
2005: G Ambe; Knut Lönnroth; Y Dholakia; J Copreaux; Matteo Zignol; N Borremans; Mukund Uplekar
Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(5):562-8.
2004: Matteo Zignol; Marta Peracchi; Gloria Tridello; Marta Pillon; Federica Fregonese; Ruggiero D'Elia; Luigi Zanesco; Simone Cesaro
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Cancer 2004;101(3):635-41.
2003: Gyanu Lamichhane; Matteo Zignol; NATALIE BLADES; Deborah E Geiman; Annette Dougherty; Jacques H Grosset; Karl W Broman; William R Bishai
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(12):7213-8.
2002: mario saia; M Castoro; Francesco Meneghetti; E Massarotto; E Narne; Matteo Zignol; D Donato
[Occupational injuries with biological risk at a hospital].
Giornale italiano di medicina del lavoro ed ergonomia 2002;24(4):438-40.
2002: Dino Sgarabotto; Riccardo Cusinato; Elena Narne; Fabio Scano; Matteo Zignol; Antonio Gambino; Anna Maria Cattelan; Francesco Meneghetti; Paolo Cadrobbi
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
Scandinavian journal of infectious diseases 2002;34(2):122-6.